Human Gene Sequencing Market Report 2023: Plummeting Sequencing Costs Presents Lucrative Opportunities for New Players, End-Uses & Technologies
Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.
Will all newborns receive genetic testing at birth? Is COVID-19 holding the industry back? Where are the over 800 locations that have high throughput sequencing devices?
The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out to 2026. The report includes detailed breakouts for 14 countries and 5 regions.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
The report includes five year market forecasts.
Market Dynamics
Growth Drivers
New Diagnoses
Wellness and Prevention
Fertility Technology
Cancer - Screening, Management and Monitoring
Growth Limitations
Increased Competition Lowers Price
Lower Costs
Healthcare Cost Concerns Curtail Growth
Key Topics Covered:
1 Market Guides
1.1 Human Gene Sequencing Markets - Strategic Situation Analysis & COVID Impact
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
2.1 Gene Sequencing Definition In This Report
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 U.S. Medical Market and laboratory Testing - Perspective
2.5 Genetic Testing vs. Gene Sequencing
3 Global Listing of Sequencer Installed Base - Location & Contacts
3.1 Notes to Installed Base Listing
3.2 Illumina Installed Base
4 Market Overview
4.1 Market Participants Play Different Roles
4.1.1 Instrument Manufacturer
4.1.2 Independent lab specialized/esoteric
4.1.3 Independent lab national/regional
4.1.4 Independent lab analytical
4.1.5 Public National/regional lab
4.1.6 Hospital lab
4.1.7 Physician lab
4.1.8 DTC Lab
4.1.9 Sequencing Labs
4.1.10 Audit body
4.2 Human Gene Sequencing -Markets, Examples and Discussion
4.2.1 Inherited Disease - Not what it used to be
4.2.1.1 Clinical and Research Lines Blur
4.2.1.2 Genetic Counselling - Not so simple anymore
4.2.1.3 The Genetic Blizzard - Issues of Access and Payment
4.2.2 Newborn Screening - The Standard of Care
4.2.2.1 Newborn Screening - Do Parents Want to Know?
4.2.3 NIPT - We've Only Just Begun
4.2.3.1 NIPT, IVF and the Fertility Practice - PGS, PGD, CCS
4.2.3.2 NIPT in the Future - Beyond Inherited Disease
4.2.4 Oncology - Understanding Two Worlds
4.2.4.1 The Tumor - A Sequence of Sequencing
4.2.4.2 The Tumor - Biopsy and Liquid Biopsy
4.2.4.3 The Human Genome - Predisposition and Prognosis
4.2.5 Pharmacogenomics
4.2.5.1 Sequencing Not the Only Player
4.2.5.2 New Roles for Old Drugs - A Research Bonanza?
4.2.6 Direct To Consumer - More Than Meets the Eye
4.2.6.1 DTC - How Many Segments?
4.3 Industry Structure
4.3.1 Hospital's Testing Share
4.3.2 The Rise of the Sequencing Lab
4.3.3 Sequencing as a Commodity
4.3.4 Informatics
4.3.5 Instrument Manufacturer Role
4.3.6 Healthcare Industry Impacts - Still Struggling
4.3.7 Can the Healthcare Industry Adapt?
4.3.8 Genetic Counselling as an Industry
4.3.9 Sequencing Adoption and Cannibalization
5 Market Trends
6 Human Gene Sequencing Recent Developments
7 Profiles of Key Companies
8 The Global Market for Human Genome Sequencing
8.1 Global Market Overview by Country
8.2 Global Market by Application - Overview
8.3 Global Market by Technology - Overview
8.4 Global Market by Workflow - Overview
8.4.1 Table - Global Market by Workflow
8.5 Global Market by Product - Overview
9 Market Sizes by Application
9.1 Hereditary Gene Sequencing Market
9.2 NIPT Gene Sequencing Market
9.3 Oncology Market
9.4 Psychology Market
9.5 WGES Gene Sequencing Market
9.6 Pharmacogenomics Market
9.7 DTC Gene Sequencing Market
9.8 Research Gene Sequencing Market
9.9 Other Application Market
10 Market Sizes by Technology
10.1 Sanger Sequencing Market
10.2 NGS/2G Market
10.3 3G/Long Market
10.4 Other Technology Market
11 Market Sizes by Workflow
11.1 Sequencing Market
11.2 Sample Prep Market
11.3 Analysis Market
12 Market Sizes by Product
12.1 Instruments Market
12.2 Consumables Market
12.3 Software & Services Market
13 Vision of the Future of Human Gene Sequencing
14 Appendices
14.1 United States Medicare System: January 2022 laboratory Fees Schedule
14.2 The Whole Genome Sequence of SARS-CoV-2
14.3 Methodology
14.3.1 Authors
14.3.2 Sources
Companies Mentioned
10x Genomics, Inc
23andME Inc
Abbott Diagnostics
AccuraGen Inc
Adaptive Biotechnologies
Admera Health, LLC
Agena Bioscience, Inc
Agilent
Akonni Biosystems
Ancestry.com LLC
Anchor Dx
Aperiomics
Arc Bio
ArcherDx, Inc
ARUP Laboratories
Asuragen
Baylor Miraca Genetics Laboratories
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bio-Rad Laboratories, Inc
Bio-Techne
Bioarray Genetics
Biocept, Inc
Biodesix Inc
BioFluidica
BioGenex
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
C2i Genomics
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Centogene
Cepheid (now Danaher)
Chronix Biomedical
Circulogene
Clinical Genomics
Color Genomics
Complete Genomics, Inc. - A BGI Company
Cynvenio
Dante Labs
Datar Cancer Genetics Limited
Diasorin S.p.A
Epic Sciences
Epigenomics AG
Eurofins Scientific
Excellerate Bioscience
Exosome Diagnostics
Fabric Genomics
Fluidigm Corp
Foundation Medicine
Freenome
FUJIFILM Wako Diagnostics
Fujirebio
Fulgent Genetics
GE Global Research
Gene by Gene, Ltd.
Genedrive
GeneFirst Ltd
Genetron Health (Beijing) Co., Ltd
Genewiz
Genomics England
Genomics Personalized Health (GPH)
GenomOncology
Genzyme Corporation
Grail, Inc
Grifols
Guardant Health
Guardiome
HeiScreen
Helix
Helomics
Hologic
Horizon Discovery
HTG Molecular Diagnostics
Human Longevity, Inc
iCellate
Illumina
Incell Dx
Inivata
Integrated Diagnostics
Invitae Corporation
Invivoscribe
Karius
Lexagene
Macrogen
MDNA Life SCIENCES, Inc
MDx Health
Medgenome
Meridian Bioscience
Mesa Biotech
MIODx
miR Scientific
MNG Labs
Molecular MD
NantHealth, Inc
Natera
Nebula Genomics
NeoGenomics
Novogene Bioinformatics Technology Co., Ltd
Omega Bioservices
OncoDNA
OpGen
ORIG3N, Inc
Origene Technologies
Oxford Nanopore Technologies
Panagene
Perkin Elmer
Personal Genome Diagnostics
Personalis
Precipio
PrecisionMed
Promega
Protagen Diagnostics
Qiagen Gmbh
Quantumdx
Regeneron Pharmaceuticals
Roche Molecular Diagnostics
Roswell Biotechnologies
Seegene
SeLux Diagnostics
Sequencing.com
Siemens Healthineers
simfo GmbH
Singlera Genomics Inc
SkylineDx
Stratos Genomics
Sure Genomics, Inc
Sysmex Inostics
Sysmex
Tempus Labs, Inc.
Thermo Fisher Scientific Inc
Veritas Genetics
Volition
For more information about this report visit https://www.researchandmarkets.com/r/nirer1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900